News Summary
The 14th Annual Outsourcing in Clinical Trials (OCT) Southeast 2025 conference will take place on April 1-2 in Raleigh-Durham. The event will focus on patient involvement in clinical research, CRO-sponsor dynamics, and the implications of the BIOSECURE Act. Industry leaders will discuss various aspects of clinical trials, including diversity and community engagement. This conference aims to foster collaboration and innovative ideas in the ever-evolving landscape of clinical research.
Get Ready for the 14th Annual Outsourcing in Clinical Trials Conference!
The 14th Annual Outsourcing in Clinical Trials (OCT) Southeast 2025 conference is just around the corner! Mark your calendars for April 1–2 as industry leaders and experts gather to dive into the fascinating world of clinical trials. This year, the event will take place in the vibrant Raleigh-Durham Research Triangle, a hub for innovation and research.
Focusing on Patients and Partnerships
This year’s conference is all about exploring the essential role of patients in clinical research. As the spotlight increasingly shines on patient voices, it’s clear that their input is invaluable for driving participation in clinical studies.
Attendees will engage in meaningful discussions about different models of CRO-sponsor relationships, especially in this ever-changing regulatory environment. This conversation is crucial, as improvements in how clinical trials involve patients can significantly impact outcomes and community engagement.
Key Talkers on Day One
Kicking off the conference will be a talk from the cofounder and COO of a leading patient advocacy consultancy. Their insights on the importance of the patient voice in the clinical development process will set the stage for lively discussions over the next two days.
On the first day, other notable discussions will include insights from professionals at major companies such as AstraZeneca, UCB, and Macrogenics. They’ll address how to enhance patient-centric considerations in clinical trials, making sure patients feel seen and heard.
Diversity Matters
A significant highlight this year is a discussion led by a prominent figure focused on diversity initiatives in clinical trials. This session will tackle critical aspects such as race, age, and geographic factors, examining how these considerations can shape the future of clinical research.
However, it’s important to note that recent political developments have raised concerns about the sustainability of these diversity initiatives. Proposed funding cuts targeting Diversity, Equity, and Inclusion (DEI) programs could impact progress, making this conversation even more pressing.
Community Organizers Take Center Stage
The afternoon of the first day will showcase a session highlighting the role of community organizers. Their work is vital when it comes to improving perceptions of clinical research among patient groups. Understanding and sharing these experiences can make a world of difference when creating a more inclusive environment for clinical trials.
Learn from Each Other on Day Two
Day two promises to be equally stimulating, as delegates are encouraged to share their experiences surrounding clinical partnerships. These shared insights can lead to new ideas and foster collaboration within the industry.
A panel discussion will focus on determining the ideal outsourcing model for sponsor-outsourcing partnerships, weighing the advantages and disadvantages of full-service outsourcing (FSO) versus functional service provider (FSP) models. With representatives from both small and medium-sized biotech companies participating, the discussion will provide a wealth of knowledge.
The BIOSECURE Act and Its Implications
Another significant area of discussion will be the BIOSECURE Act. This piece of legislation represents a considerable shift in the outsourcing landscape, and understanding its implications is crucial for all stakeholders involved.
Conclusion
The 14th Annual Outsourcing in Clinical Trials conference promises to be a landmark event, focusing on how to better include patients in clinical research and enhance partnerships in an evolving regulatory landscape. With expert insights and enriching conversations lined up, this is one conference you won’t want to miss!
Deeper Dive: News & Info About This Topic
HERE Resources
Additional Resources
- Clinical Trials Arena: Integrating Patients into Clinical Research
- Wikipedia: Clinical Trial
- ABC11: Federal Judge Blocks Funding Cuts for Medical Research
- Google Search: Funding Cuts in Medical Research
- Axios: North Hills Lands a Pharma Headquarters
- Google Scholar: Accessibility in Clinical Trials
- WRAL: Federal Funding Pause Threatens North Carolina Research
- Encyclopedia Britannica: Clinical Research
